Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
PM Patel, CH Ottensmeier, C Mulatero… - …, 2018 - Taylor & Francis
ABSTRACT A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
[PDF][PDF] Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated …
PM Patel, CH Ottensmeier, C Mulatero, P Lorigan… - 2018 - researchgate.net
ABSTRACT A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
PM Patel, CH Ottensmeier, C Mulatero… - …, 2018 - eprints.soton.ac.uk
A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-2/gp100
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
[PDF][PDF] Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated …
PM Patel, CH Ottensmeier, C Mulatero, P Lorigan… - 2018 - core.ac.uk
ABSTRACT A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
PM Patel, CH Ottensmeier, C Mulatero… - …, 2018 - research.manchester.ac.uk
Abstract A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
PM Patel, CH Ottensmeier, C Mulatero… - … - nottingham-repository.worktribe.com
A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-2/gp100
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
[PDF][PDF] Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated …
PM Patel, CH Ottensmeier, C Mulatero, P Lorigan… - 2018 - scancell.co.uk
ABSTRACT A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
PM Patel, CH Ottensmeier, C Mulatero… - … - eprints.nottingham.ac.uk
A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-2/gp100
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
P Patel, C Ottensmeier, C Mulatero, PC Lorigan… - 2018 - christie.openrepository.com
A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-2/gp100
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
was evaluated in patients with metastatic melanoma. Each patient received SCIB1 via …
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with …
PM Patel, CH Ottensmeier, C Mulatero, P Lorigan… - …, 2018 - europepmc.org
ABSTRACT A DNA vaccine, SCIB1, incorporating two CD8 and two CD4 epitopes from TRP-
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
2/gp100 was evaluated in patients with metastatic melanoma. Each patient received SCIB1 …
